Sarepta has issued a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl) following a second reported case of acute liver failure resulting in death.

A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys ...

The only option left for the doctors was liver transplantation and Anakendu's mother came to her rescue by volunteering to ...

The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

Acute liver failure (ALF) in children differs from that observed in adults in both the etiologic spectrum and the clinical picture. Children, particularly very young ones, do not demonstrate ...

Sarepta Therapeutics on Sunday said there had been a second reported case of acute liver failure resulting in death after a patient received the company's gene therapy for a rare form of muscular ...

clinic.cat; pgines{at}clinic.ub.es Acute-on-chronic liver failure (ACLF) is a syndrome characterised by acute decompensation of chronic liver disease associated with organ failures and high short-term ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...

Your liver grows as you age, though certain health conditions, including acute hepatitis and fatty liver disease, can cause an enlarged liver. A large liver doesn’t always cause symptoms.

Another person treated with Elevidys suffered acute liver failure, leading Sarepta to discontinue treatment in certain ...

Chronic liver failure develops gradually, and symptoms worsen as the disease progresses. Chronic liver failure can be caused by several different conditions. Acute liver failure happens suddenly and ...